SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015537
Filing Date
2024-11-13
Accepted
2024-11-13 16:30:28
Documents
72
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20240930x10q.htm   iXBRL 10-Q 1316937
2 EX-10.1 glyc-20240930xex10d1.htm EX-10.1 22692
3 EX-10.2 glyc-20240930xex10d2.htm EX-10.2 19938
4 EX-10.3 glyc-20240930xex10d3.htm EX-10.3 59349
5 EX-10.4 glyc-20240930xex10d4.htm EX-10.4 51145
6 EX-31.1 glyc-20240930xex31d1.htm EX-31.1 16962
7 EX-31.2 glyc-20240930xex31d2.htm EX-31.2 16778
8 EX-32.1 glyc-20240930xex32d1.htm EX-32.1 9441
  Complete submission text file 0001558370-24-015537.txt   5793608

Data Files

Seq Description Document Type Size
9 EX-101.SCH glyc-20240930.xsd EX-101.SCH 38642
10 EX-101.CAL glyc-20240930_cal.xml EX-101.CAL 36255
11 EX-101.DEF glyc-20240930_def.xml EX-101.DEF 177871
12 EX-101.LAB glyc-20240930_lab.xml EX-101.LAB 373495
13 EX-101.PRE glyc-20240930_pre.xml EX-101.PRE 314985
75 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20240930x10q_htm.xml XML 822748
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 241454881
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)